Related Experiment Video

Updated: Aug 29, 2026

Quantifying Glomerular Permeability of Fluorescent Macromolecules Using 2-Photon Microscopy in Munich Wistar Rats
11:13

Quantifying Glomerular Permeability of Fluorescent Macromolecules Using 2-Photon Microscopy in Munich Wistar Rats

Published on: April 17, 2013

Beta-2 microglobulin in ESRD: an in-depth review

James F Winchester1, Jamie A Salsberg, Nathan W Levin

  • 1RenalTech International, LLC, New York, NY 10021, USA. jamesw@renaltech.com

Advances in Renal Replacement Therapy
|December 19, 2003
PubMed

Insights

Beta-2 microglobulin (B2M) causes dialysis-related amyloidosis in kidney failure. Using dialysis membranes with higher B2M clearance may reduce mortality risk.

Area of Science:

  • Nephrology
  • Biochemistry

Background:

  • Beta-2 microglobulin (B2M) is a low-molecular-weight protein implicated in end-stage renal disease.
  • B2M retention, tissue deposition, fibril aggregation, and glycosylation contribute to dialysis-related amyloidosis (DRA).

Purpose of the Study:

  • To investigate the role of beta-2 microglobulin in dialysis-related amyloidosis.
  • To explore methods for improving B2M removal during dialysis.
  • To assess the impact of dialysis membrane characteristics on patient mortality.

Main Methods:

  • Review of studies on beta-2 microglobulin in end-stage renal disease.
  • Analysis of factors influencing DRA onset, including membrane type and hemodiafiltration volume.
  • Evaluation of adsorptive methods for B2M removal.
  • Comparison of mortality risk associated with different dialysis membrane clearances of B2M.

Main Results:

  • Noncellulosic membranes, particularly with high-volume hemodiafiltration, may prolong DRA onset.
  • Adsorptive techniques show promise for enhancing B2M removal.
  • Dialysis membranes with higher B2M clearance appear to be associated with a reduced mortality risk.

Conclusions:

  • Effective removal of beta-2 microglobulin is crucial in managing end-stage renal disease and preventing dialysis-related amyloidosis.
  • Dialysis membrane selection can influence patient outcomes, including mortality.
  • Further research into advanced dialysis techniques and membrane technologies is warranted.

Related Concept Videos

Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate01:25

Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate

The glomerular filtration rate (GFR) is a critical indicator of kidney health, reflecting how well the kidneys filter blood. Changes in GFR can signal potential kidney impairment, necessitating accurate measurement methods to monitor kidney function effectively.Various molecules can serve as markers for GFR measurement, with the ideal marker meeting several specific criteria. It must freely filter at the glomerulus, avoid reabsorption or secretion by the renal tubules, remain unmetabolized, not...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...